Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: Responders versus nonresponders

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

384

HTML

2664

Figures (1-5)

212

Tables (1-3)

171

Sum=3431

Jun 7, 2006 (publication date) through Aug 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Jun 7, 2006; 12(21): 3386-3392
Published online Jun 7, 2006. doi: 10.3748/wjg.v12.i21.3386

Full Size Figure Download Figure

Figure 1 A: Rectal NO levels in UC; B: Rectal NO levels in CD.

Citation: Ljung T, Lundberg S, Varsanyi M, Johansson C, Schmidt PT, Herulf M, Lundberg JO, Hellström PM. Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: Responders versus nonresponders. World J Gastroenterol 2006; 12(21): 3386-3392
URL: https://www.wjgnet.com/1007-9327/full/v12/i21/3386.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i21.3386